Outlook Therapeutics Announces Closing of $55 Million Public Offering of Stock and Warrants

Outlook Therapeutics, Inc. is scheduled to close a public offering of 55,555,556 shares of common stock and accompanying warrants, aiming to raise approximately $55.0 million in gross proceeds. Senior executives and the largest stockholder participated in the offering.